Reuters separately reported an FDA decision target of April 10, 2026
Patients are advised to start with the lowest dose (2.5 mg) and gradually titrate upward every four weeks to minimize these effects
D., Luo J
The technical term is it's a GLP-1 receptor agonist, and just like GLP-1, it increases insulin release, it lowers blood sugar, the stomach empties slower, but it was different from GLP-1 in one really important way
A decade on from the first immunotherapy approval, how much do we know about these cryptic harms and how do we balance their risk with the undeniable benefits of immunotherapy
Key Facts of The Glutathione Supplement Case The product involved was an online supplement, reportedly priced around RM20, marketed for skin-lightening